Fundraising Fox
Prenosis
Founded 2014 · 44 employees on LinkedIn · 7 known investors
Find your way into Prenosis
Sign up to find every way you can get introduced to Prenosis
- Your email: who you already know at Prenosis, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Prenosis team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Prenosis develops AI-powered precision medicine diagnostics for acute care, built on its Immunix platform and a biobank of clinical data for infection. Its Sepsis ImmunoScore is an FDA-authorized AI diagnostic that integrates biomarkers and clinical data into hospital electronic medical records to diagnose sepsis and predict patient outcomes.
Investors · 7
Also in the syndicate · 5
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJan 2026 · 2 sources
PACE Healthcare Capital (lead), Carle Health, Global Health Investment Corporation (GHIC), Illinois Department of Commerce and Economic Opportunity (DCEO), Labcorp Venture Fund, UC Investments, UCI Health Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $2M |
| National Science Foundation | Phase II | 2018 | $704.5K |
| National Science Foundation | Phase I | 2017 | $150K |
| Centers for Disease Control and Prevention (CDC)Centers for Disease Control and Prevention | Phase I | 2017 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Prenosis do?
- Prenosis develops AI-powered precision medicine diagnostics for acute care, built on its Immunix platform and a biobank of clinical data for infection. Its Sepsis ImmunoScore is an FDA-authorized AI diagnostic that integrates biomarkers and clinical data into hospital electronic medical records to diagnose sepsis and predict patient outcomes.
- Who are Prenosis's investors?
- Prenosis's investors include Global Health Investment Corporation, PACE Healthcare Capital.